Page last updated: 2024-09-04

2-(1-octynyl)adenosine and calcimycin

2-(1-octynyl)adenosine has been researched along with calcimycin in 1 studies

Compound Research Comparison

Studies
(2-(1-octynyl)adenosine)
Trials
(2-(1-octynyl)adenosine)
Recent Studies (post-2010)
(2-(1-octynyl)adenosine)
Studies
(calcimycin)
Trials
(calcimycin)
Recent Studies (post-2010) (calcimycin)
230311,94640444

Protein Interaction Comparison

ProteinTaxonomy2-(1-octynyl)adenosine (IC50)calcimycin (IC50)
XBP1Homo sapiens (human)1.41
DNA damage-inducible transcript 3 proteinMus musculus (house mouse)0.16

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kimura, J; Matsuoka, I; Nakanishi, H; Ohkubo, S; Ono, T1

Other Studies

1 other study(ies) available for 2-(1-octynyl)adenosine and calcimycin

ArticleYear
Effects of YT-146 [2-(1-octynyl) adenosine], an adenosine A2A receptor agonist, on cAMP production and noradrenaline release in PC12 cells.
    Japanese journal of pharmacology, 1998, Volume: 78, Issue:3

    Topics: Adenosine; Adenosine Triphosphate; Alkynes; Animals; Bucladesine; Calcimycin; Calcium; Carbachol; Cholinergic Agonists; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; Ionophores; Isoquinolines; Membrane Potentials; Norepinephrine; PC12 Cells; Potassium Chloride; Purinergic P1 Receptor Agonists; Rats; Receptor, Adenosine A2A; Sulfonamides; Thionucleotides; Tritium; Vasodilator Agents

1998